MedTrace Logo

Giessen Stroke Registry

NCT05295862 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2023-12-01

No results posted yet for this study

Summary

The aim of the planned study project is to assess the current situation regarding the treatment of patients with stroke. Specifically, various treatment strategies are to be associated and correlated with clinical endpoints, mortality or functional outcome in order to generate arguments for or against individual aspects of therapy. The focus will be on unresolved treatment approaches in acute therapy (e.g. periprocedural management, such as blood pressure, blood glucose, temperature, or airway management, during recanalizing therapies) as well as in secondary prevention on the stroke unit or intensive care unit, such as starting point, mode, and dosage of antithrombotic therapies.

Conditions

  • Stroke, Acute
  • Comorbidities and Coexisting Conditions
  • Critical Care

Sponsors & Collaborators

  • University of Giessen

    lead OTHER

Principal Investigators

  • Tobias Braun, M.D. · University of Giessen

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-30
Primary Completion
2026-12-31
Completion
2027-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05295862 on ClinicalTrials.gov